Targeted News Service

Emory University Winship Cancer Institute: Winship Administers First U.S. Dose of Investigational in Vivo CAR-T Therapy in Multiple Myeloma Trial
May 14, 2026

ATLANTA, Georgia, May 14 -- Emory University Winship Cancer Institute issued the following news release:

* * *

Winship administers first U.S. dose of investigational in vivo CAR-T therapy in multiple myeloma trial

Physicians and researchers at Winship Cancer Institute of Emory University announced today they have administered the first investigational in vivo CAR-T cell therapy in the United States for relapsed and refractory multiple myeloma, marking an im . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form